top of page
it's where dermatology lives




1/2


Potential Tx for hypopigmentation?
Ampyrone increases pigmentation in a human 3D epidermal model, The top row shows visible epidermal darkening after treatment every other day with ampyrone for 21 days as compared to negative control. The bottom row shows magnification of epidermal cells revealing increased melanin synthesis in the ampyrone treated melanocytes as compared to negative control. Positive control is alpha-melanocyte stimulating hormone (αMSH) plus beta-fibroblast growth factor (βFGF). Photo by Dr.
Allan Ryan
Jul 202 min read


Changes in collagen organization, chirality predate visible damage
Ali Haider, a graduate student at HU and WPI-SKCM2 and first author of the study, observes the skin structure using confocal microscopy to investigate collagen organization and extracellular matrix remodelling. Photo by Ali Haider / Hiroshima University An international team led by researchers at Hiroshima University has developed a new way to detect subtle, early-stage changes in human skin collagen before any visible signs of damage appear. In the study, published in ACS Na
John Evans
Jul 172 min read


Bionic cooling skin developed for infected wounds
Shi, S., Zhou, H., Ming, Y. et al. Bionic Cooling Skin for Infected Wound Healing. Nano-Micro Lett. 2026; 18:390. https://doi.org/10.1007/s40820-026-02240-6 CC-BY 4.0 Researchers in Hong Kong and mainland China have developed a bionic “cooling skin” dressing that is reported to protect infected wounds, enhance patient comfort, and deliver on‑demand antibacterial activity. The article was published in Nano-Micro Letters. The team, led by investigators at The Hong Kong Polytech
Allan Ryan
Jul 132 min read


Comorbidities an important consideration in HS treatment
Photo by BRI72783 via Wikimedia Commons There is greater appreciation of potential comorbidities in patients with hidradenitis suppurativa (HS), both in the adult and pediatric setting, according to a special report in the June 2026 edition of The Chronicle of Skin & Allergy. Comorbidities are common in patients with HS, and some of the most challenging to manage include inflammatory bowel disease, inflammatory arthritis, polycystic ovary syndrome, metabolic syndrome, depre
Allan Ryan
Jun 292 min read
Featured Posts


bottom of page
